Oscor Medical Corp Permanent Pacing Lead
510(k) K912867
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK912867 | Date4 Feb 1992 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
This device is a Permanent Pacemaker Electrode, classified as a Class III medical device under FDA regulations. It is designed for implantation within the heart to provide electrical stimulation for pacing purposes, ensuring proper cardiac rhythm in patients with bradycardia or other conduction disorders. The lead delivers timed electrical impulses to regulate heart contractions, supporting long-term cardiac function in chronic pacing applications.
The Permanent Pacing Lead is intended for single-use implantation and must be handled under sterile conditions. It is supplied as a sterile, pre-packaged device and requires surgical insertion by a qualified healthcare professional. Compliance with FDA 510(k) clearance (K912867) ensures adherence to regulatory standards for cardiovascular devices. Storage and handling follow manufacturer guidelines to maintain sterility and functionality, with no MRI compatibility specified.
Other devices from Oscor Medical Corp.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of this permanent pacing lead, and how is it intended to be used in clinical practice?
This permanent pacing lead is designed to be implanted within the heart to deliver timed electrical impulses, helping regulate heart contractions for patients with bradycardia or conduction disorders. It is intended for chronic pacing applications, ensuring long-term cardiac rhythm support. The lead must be surgically implanted by a qualified healthcare professional under sterile conditions, as it is a single-use device.
How is the device supplied, and what precautions should be taken during handling to maintain sterility?
The permanent pacing lead is supplied as a sterile, pre-packaged device. Since it is intended for single-use implantation, it must be handled under sterile conditions to prevent contamination. Adherence to manufacturer guidelines for storage and handling is critical to preserve sterility and functionality before use.
Is this device reusable, or is it meant for one-time use after implantation?
This device is explicitly intended for single-use implantation only. Once implanted, it is not designed to be removed or reused, so proper sterile handling and disposal after use are essential.
What regulatory pathway does this device follow, and how does that affect its use in clinical settings?
This device follows the FDA 510(k) clearance pathway, with a clearance number of K912867, and is classified as a Class III medical device. This means it has undergone rigorous review by the FDA’s Cardiovascular (CV) advisory committee to ensure safety and effectiveness for its intended use in chronic cardiac pacing. Clinicians can rely on this regulatory clearance as evidence of compliance with FDA standards.